Apparel - Retail
Compare Stocks
2 / 10Stock Comparison
DBI vs CROX
Revenue, margins, valuation, and 5-year total return — side by side.
Apparel - Footwear & Accessories
DBI vs CROX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Apparel - Retail | Apparel - Footwear & Accessories |
| Market Cap | $292M | $5.21B |
| Revenue (TTM) | $2.89B | $4.02B |
| Net Income (TTM) | $-2M | $-104M |
| Gross Margin | 51.8% | 58.1% |
| Operating Margin | 1.2% | 21.5% |
| Forward P/E | — | 7.8x |
| Total Debt | $1.29B | $1.61B |
| Cash & Equiv. | $45M | $130M |
DBI vs CROX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Designer Brands Inc. (DBI) | 100 | 113.9 | +13.9% |
| Crocs, Inc. (CROX) | 100 | 363.3 | +263.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DBI vs CROX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DBI carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 4 yrs, beta 2.66, yield 2.8%
- Better valuation composite
- -0.1% margin vs CROX's -2.6%
CROX is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -1.5%, EPS growth -109.4%, 3Y rev CAGR 4.4%
- 12.5% 10Y total return vs DBI's -52.6%
- Lower volatility, beta 1.18, current ratio 1.27x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.5% revenue growth vs DBI's -2.1% | |
| Value | Better valuation composite | |
| Quality / Margins | -0.1% margin vs CROX's -2.6% | |
| Stability / Safety | Beta 1.18 vs DBI's 2.66, lower leverage | |
| Dividends | 2.8% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +128.7% vs CROX's +3.3% | |
| Efficiency (ROA) | -0.1% ROA vs CROX's -2.4%, ROIC 1.7% vs 21.7% |
DBI vs CROX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DBI vs CROX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CROX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CROX and DBI operate at a comparable scale, with $4.0B and $2.9B in trailing revenue. Profitability is closely matched — net margins range from -0.1% (DBI) to -2.6% (CROX).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.9B | $4.0B |
| EBITDAEarnings before interest/tax | $51M | $946M |
| Net IncomeAfter-tax profit | -$2M | -$104M |
| Free Cash FlowCash after capex | $128M | $671M |
| Gross MarginGross profit ÷ Revenue | +51.8% | +58.1% |
| Operating MarginEBIT ÷ Revenue | +1.2% | +21.5% |
| Net MarginNet income ÷ Revenue | -0.1% | -2.6% |
| FCF MarginFCF ÷ Revenue | +4.4% | +16.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.2% | -1.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +45.8% | -4.2% |
Valuation Metrics
DBI leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, CROX's 6.9x EV/EBITDA is more attractive than DBI's 15.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $292M | $5.2B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $6.7B |
| Trailing P/EPrice ÷ TTM EPS | -34.90x | -69.39x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.81x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 15.53x | 6.92x |
| Price / SalesMarket cap ÷ Revenue | 0.10x | 1.29x |
| Price / BookPrice ÷ Book value/share | 1.33x | 4.36x |
| Price / FCFMarket cap ÷ FCF | 3.35x | 7.90x |
Profitability & Efficiency
Evenly matched — DBI and CROX each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
DBI delivers a -0.5% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-8 for CROX. CROX carries lower financial leverage with a 1.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBI's 4.56x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -0.5% | -7.5% |
| ROA (TTM)Return on assets | -0.1% | -2.4% |
| ROICReturn on invested capital | +1.7% | +21.7% |
| ROCEReturn on capital employed | +2.4% | +23.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 4.56x | 1.25x |
| Net DebtTotal debt minus cash | $1.2B | $1.5B |
| Cash & Equiv.Liquid assets | $45M | $130M |
| Total DebtShort + long-term debt | $1.3B | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.75x | 10.07x |
Total Returns (Dividends Reinvested)
Evenly matched — DBI and CROX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CROX five years ago would be worth $9,556 today (with dividends reinvested), compared to $4,047 for DBI. Over the past 12 months, DBI leads with a +128.7% total return vs CROX's +3.3%. The 3-year compound annual growth rate (CAGR) favors DBI at -0.3% vs CROX's -3.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -1.5% | +19.7% |
| 1-Year ReturnPast 12 months | +128.7% | +3.3% |
| 3-Year ReturnCumulative with dividends | -0.8% | -10.9% |
| 5-Year ReturnCumulative with dividends | -59.5% | -4.4% |
| 10-Year ReturnCumulative with dividends | -52.6% | +1246.4% |
| CAGR (3Y)Annualised 3-year return | -0.3% | -3.8% |
Risk & Volatility
CROX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CROX is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than DBI's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CROX currently trades 84.7% from its 52-week high vs DBI's 79.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.66x | 1.18x |
| 52-Week HighHighest price in past year | $8.75 | $122.84 |
| 52-Week LowLowest price in past year | $2.17 | $73.21 |
| % of 52W HighCurrent price vs 52-week peak | +79.8% | +84.7% |
| RSI (14)Momentum oscillator 0–100 | 49.0 | 62.4 |
| Avg Volume (50D)Average daily shares traded | 672K | 1.2M |
Analyst Outlook
DBI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates DBI as "Hold" and CROX as "Buy". Consensus price targets imply 2.7% upside for CROX (target: $107) vs -3.3% for DBI (target: $7). DBI is the only dividend payer here at 2.79% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $6.75 | $106.88 |
| # AnalystsCovering analysts | 29 | 37 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | — |
| Dividend StreakConsecutive years of raises | 4 | 0 |
| Dividend / ShareAnnual DPS | $0.19 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +23.4% | +11.3% |
CROX leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). DBI leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
DBI vs CROX: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is DBI or CROX a better buy right now?
For growth investors, Crocs, Inc.
(CROX) is the stronger pick with -1. 5% revenue growth year-over-year, versus -2. 1% for Designer Brands Inc. (DBI). Analysts rate Crocs, Inc. (CROX) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DBI or CROX?
Over the past 5 years, Crocs, Inc.
(CROX) delivered a total return of -4. 4%, compared to -59. 5% for Designer Brands Inc. (DBI). Over 10 years, the gap is even starker: CROX returned +1246% versus DBI's -52. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DBI or CROX?
By beta (market sensitivity over 5 years), Crocs, Inc.
(CROX) is the lower-risk stock at 1. 18β versus Designer Brands Inc. 's 2. 66β — meaning DBI is approximately 125% more volatile than CROX relative to the S&P 500. On balance sheet safety, Crocs, Inc. (CROX) carries a lower debt/equity ratio of 125% versus 5% for Designer Brands Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — DBI or CROX?
By revenue growth (latest reported year), Crocs, Inc.
(CROX) is pulling ahead at -1. 5% versus -2. 1% for Designer Brands Inc. (DBI). On earnings-per-share growth, the picture is similar: Crocs, Inc. grew EPS -109. 4% year-over-year, compared to -143. 5% for Designer Brands Inc.. Over a 3-year CAGR, CROX leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — DBI or CROX?
Designer Brands Inc.
(DBI) is the more profitable company, earning -0. 4% net margin versus -2. 0% for Crocs, Inc. — meaning it keeps -0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CROX leads at 22. 0% versus 1. 2% for DBI. At the gross margin level — before operating expenses — CROX leads at 57. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is DBI or CROX more undervalued right now?
Analyst consensus price targets imply the most upside for CROX: 2.
7% to $106. 88.
07Which pays a better dividend — DBI or CROX?
In this comparison, DBI (2.
8% yield) pays a dividend. CROX does not pay a meaningful dividend and should not be held primarily for income.
08Is DBI or CROX better for a retirement portfolio?
For long-horizon retirement investors, Crocs, Inc.
(CROX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 18), +1246% 10Y return). Designer Brands Inc. (DBI) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CROX: +1246%, DBI: -52. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between DBI and CROX?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
DBI pays a dividend while CROX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.